Adult attention-deficit/hyperactivity disorder, risky substance use and substance use disorders: a follow-up study among young men by Estévez-Lamorte, Natalia et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2019
Adult attention-deficit/hyperactivity disorder, risky substance use and
substance use disorders: a follow-up study among young men
Estévez-Lamorte, Natalia ; Foster, Simon ; Eich-Höchli, Dominique ; Moggi, Franz ; Gmel, Gerhard ;
Mohler-Kuo, Meichun
Abstract: We investigated whether adult attention-deficit/hyperactivity disorder (ADHD) predicts risky
substance use and substance use disorders (SUDs), and its impact on the course of these problematic
substance use patterns. Our sample included 4975 Swiss men (mean age 20 ± 1.2 years) who partici-
pated in the baseline and 15-month follow-up assessments of the Cohort Study on Substance Use Risk
Factors. We examined: (1) the contribution of ADHD, as assessed at baseline, on the risky use of al-
cohol, nicotine and cannabis, and their corresponding use disorders (AUD, NUD, CUD) at follow-up;
and (2) the association between ADHD and the course of outcomes (i.e., absence, initiation, maturing
out, persistence) over 15 months. All analyses were adjusted for socio-demographics and co-morbidity.
Men with ADHD were more likely to exhibit persistent risky alcohol and nicotine use, and to mature
out of risky cannabis use. ADHD at baseline was positively linked to AUD and negatively to CUD at
follow-up, but not to NUD. For all SUDs, ADHD had a positive association with use persistence and
maturing out. Comparing these two trajectories revealed that early age of alcohol use initiation distin-
guished between persistence and maturing out of AUD, while the course of NUD and CUD was related
to ADHD symptoms and SUD severity at baseline. Already in their early twenties, men with ADHD are
especially likely to exhibit persistent problematic substance use patterns. Substance-specific prevention
strategies, particularly implemented before early adulthood, may be crucial to reducing the development
and persistence of pathological patterns in such individuals.
DOI: https://doi.org/10.1007/s00406-018-0958-3
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-163000
Journal Article
Accepted Version
Originally published at:
Estévez-Lamorte, Natalia; Foster, Simon; Eich-Höchli, Dominique; Moggi, Franz; Gmel, Gerhard; Mohler-
Kuo, Meichun (2019). Adult attention-deficit/hyperactivity disorder, risky substance use and substance
use disorders: a follow-up study among young men. European Archives of Psychiatry and Clinical Neu-
roscience, 269(6):667-679.
DOI: https://doi.org/10.1007/s00406-018-0958-3
1 
Adult attention-deficit/hyperactivity disorder, risky substance use and substance use disorders: 
A follow-up study among young men 
 
N. Estévez-Lamorte 1, 2, 3, 4, S. Foster 2, 3, 4, D. Eich-Höchli 5, F. Moggi 6, G. Gmel 7, 8, 9, 10, M. Mohler-Kuo 1, 2, 3,4  
 
Affiliations 
1
 La Source, School of Nursing Sciences, University of Applied Sciences and Arts, Western Switzerland, 
Lausanne 
2
 Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, 
University of Zurich, Zurich, Switzerland 
3
 Swiss Research Institute for Public Health and Addiction, Zurich, Switzerland 
4 Epidemiology, Biostatistics and Prevention Institute, Zurich, Switzerland 
5 Psychiatric University Hospital Zurich, Zurich, Switzerland 
6 University Hospital of Psychiatry, University of Bern, Bern, Switzerland 
7 Alcohol Treatment Centre, Lausanne University Hospital CHUV, Lausanne, Switzerland 
8 Addiction Switzerland, Lausanne, Switzerland  
9 Centre for Addiction and Mental Health, Toronto, Ontario, Canada  
10 University of the West of England, Bristol, United Kingdom  
 
 
Correspondence to: 
Natalia Estévez 
University of Applied Sciences and Arts Western Switzerland, la Source 
Avenue Vinet 30, 1004 Lausanne, Switzerland  
Phone: +41 79 734 92 83 
E-mail: natalia.estevezgomez@uzh.ch 
 
Addresses of co-authors 
1 University of Applied Sciences and Arts Western Switzerland, la Source, Avenue Vinet 30, 1004 Lausanne, 
Switzerland 
2 
2
 Department of Child and Adolescent Psychiatry, University of Zurich, Neumünsterallee 9, 8032 Zurich, 
Switzerland  
5 Psychiatric University Hospital Zurich, Lenggstrasse 31, 8032 Zurich, Switzerland 
6 University Hospital of Psychiatry, University of Bern, Bolligenstrasse 111, 3000 Bern 60, Switzerland 
7 Alcohol Treatment Centre, Lausanne University Hospital CHUV, Avenue Beaumont 21bis, Pavillon 2, 1011 
Lausanne, Switzerland 
8
 Addiction Switzerland P.O. Box 870, 1001 Lausanne, Switzerland 
9
 Centre for Addiction and Mental Health, 250 College St, Toronto, Ontario, M5T 1R8, Canada 
10
 University of the West of England, Frenchay Campus Coldharbour Lane, Bristol BS16 1QY, United Kingdom 
 
Acknowledgments 
We thank Joseph Studer, Charlotte Eidenbenz and Laura Werlen for their valuable input. This study has been 
supported by the Swiss National Science Foundation (grant number: 33CS30_139467) and by the Hartmann 
Müller-Foundation (grant number: 1708). 
 
3 
Abstract 
Aim: We investigated whether adult attention-deficit/hyperactivity disorder (ADHD) predicts risky substance use 
and substance use disorders (SUDs), and its impact on the course of these problematic substance use patterns. 
Methods: Our sample included 4,975 Swiss men (mean age 20 ± 1.2 years) who participated in the baseline and 
15-month follow-up assessments of the Cohort Study on Substance Use Risk Factors. We examined: 1) the 
contribution of ADHD, as assessed at baseline, on the risky use of alcohol, nicotine and cannabis, and their 
corresponding use disorders (AUD, NUD, CUD) at follow-up; and 2) the association between ADHD and the 
course of outcomes (i.e., absence, initiation, maturing out, persistence) over 15 months. All analyses were adjusted 
for socio-demographics and co-morbidity. 
Results: Men with ADHD were more likely to exhibit persistent risky alcohol and nicotine use, and to mature out 
of risky cannabis use. ADHD at baseline was positively linked to AUD and negatively to CUD at follow-up, but 
not to NUD. For all SUDs, ADHD had a positive association with use persistence and maturing out. Comparing 
these two trajectories revealed that early age of alcohol use initiation distinguished between persistence and 
maturing out of AUD, while the course of NUD and CUD was related to ADHD symptoms and SUD severity at 
baseline. 
Conclusions: Already in their early twenties, men with ADHD are especially likely to exhibit persistent 
problematic substance use patterns. Substance-specific prevention strategies, particularly implemented before 
early adulthood, may be crucial to reducing the development and persistence of pathological patterns in such 
individuals. 
 
Key words: adult attention-deficit/hyperactivity disorder, risky substance use, substance use disorder, alcohol, 
nicotine, cannabis 
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Introduction  
Attention-deficit/hyperactivity disorder (ADHD) is a neuropsychiatric disorder, which often has its onset and is 
most frequent during childhood, but may persist into adulthood [1, 2]. Thus, it can affect mental health and 
functioning in several life domains throughout one’s entire life span [2–5]. In particular, ADHD has often been 
associated with problematic substance use patterns, like risky substance use and substance use disorders (SUDs) 
[6–12]. For instance, ADHD has been linked to a higher rate of SUDs related to various licit and illicit substances, 
more severe addiction, and a negative course of pathology (e.g., persistent symptoms, higher rate of relapse) [13, 
14]. Thus, ADHD is considered a risk factor for developing and maintaining substance use problems. However, 
longitudinal studies addressing the contribution of ADHD on risky substance use and SUDs have demonstrated 
inconsistent results. While some studies have failed to identify an association between ADHD and problematic 
use patterns, others have confirmed it for some, but not other substances [10, 11, 15]. Consequently, it remains 
unclear whether the presence of ADHD truly is predictive of problematic use patterns at all; and, if so, for which 
substances. 
Several methodological limitations might contribute to this inconsistency. Most previous investigations might have 
been biased by their use of non-representative convenience samples (e.g., clinical samples). Additionally, subject 
samples often were small; as such, adjustments for socio-demographics and co-morbidity, especially for conduct 
problems and antisocial behaviour, were unattainable in many studies and could have been confounders [10, 11]. 
In other investigations in which potential confounders were adjusted for in the analyses, the study’s power might 
have been insufficient to detect any significant contribution of ADHD on outcomes [12, 16]. Furthermore, many 
existing investigations addressing the contribution of ADHD on SUDs often followed children only into 
adolescence, failing to assess outcomes in young adults, even though substance use problems have their onset 
predominantly during this period of life [17]. Thus, in some studies, the absence of significant results might merely 
be because the participants were too young to develop such disorders [10, 15].  
The period between late adolescence and young adulthood is a vantage point from which to examine whether 
ADHD influences the development and course of problematic substance use patterns. During this critical stage of 
life, individuals must deal with a number of normative developmental tasks that are accompanied by major changes 
in every life domain [18]. Additionally, substance use and related problems often increase, especially in men [19, 
20]. Given the disadvantages that subjects suffering from ADHD experience in many relevant life domains, they 
may have more difficulties facing the new challenges that arise during this critical period and may, therefore, be 
at higher risk of exhibiting risky substance use or developing SUDs than their peers [6]. Indeed, in a cross-sectional 
study on a large, representative sample of young Swiss men, those with ADHD, were 1.5-2 times more likely than 
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those without to exhibit the risky use of licit and illicit substances, and up to two times more likely to report SUDs, 
independently of socio-demographics and co-morbidity [12]. These findings also are consistent with those reported 
for a representative sample of the U.S. adult population [21]. However, given the cross-sectional nature of these 
investigations, causal inferences could not be drawn from the observations. In a recent longitudinal study by Vogel 
and colleagues [22] that used data from the same cohort of Swiss men as in [12] and investigated changes in 
substance use (i.e., between baseline and 15-month follow-up), young men with ADHD were not only more likely 
to use alcohol, nicotine and cannabis at baseline than men without ADHD, their consumption remained stable over 
a period of 15 months. Furthermore, in this study, men with ADHD who did not already use illicit substances at 
baseline were more likely to initiate their consumption between baseline and follow-up than those without ADHD. 
However, the investigators focused primarily on substance use and did not investigate changes in more severe 
patterns such as risky substance use and SUDs. It, therefore, remains unclear whether these results are transferable 
to problematic substance use patterns. 
The first aim of the present study was to examine whether ADHD at baseline predicts the risky use of particular 
substances (i.e., alcohol, nicotine and cannabis) and related SUDs in young adults followed for a period of 15 
months. The second aim was to examine the association between ADHD and the course of these problematic use 
patterns, providing a more thorough investigation of the effects of ADHD on possible changes (i.e., initiation or 
maturing out of problematic patterns) or persistent patterns (i.e., absence or persistence of problematic patterns) 
over the investigation period. To this end, we used data from a large, population-based sample of young Swiss 
men who were surveyed twice, with an interval of 15 months between the assessments. We hypothesized that, in 
young men, ADHD would predict the risky use of alcohol, nicotine and cannabis, as well as of related SUDs over 
the course of observation. Additionally, we hypothesized that men suffering from ADHD would be more likely to 
report the initiation and persistence of risky use and SUDs. To our knowledge, this is the largest sample of young 
men evaluated, within a longitudinal, population-based study, for the influence of ADHD on problematic substance 
use outcomes. 
 
Methods 
Data were drawn from the ‘Cohort Study on Substance Use Risk Factors’ (C-SURF), which has been 
longitudinally investigating a cohort of young Swiss men. The protocol was approved by the Ethics Committee 
for Clinical Research at Lausanne University Medical School (Protocol No 15/07). 
Participants were recruited at three of the six army recruitment centres in Switzerland, covering 21 of the 26 Swiss 
cantons. In Switzerland, army recruitment is mandatory; therefore, all young men must attend a formal evaluation 
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to determine their eligibility for military or civil service, versus no service. As there is no pre-selection to army 
conscription, a representative sample of young Swiss men was accessible for study participation. All aspects of 
the study and the men’s decision to participate were entirely independent of the army. The centres were used 
exclusively to enrol participants. The current study used data from the baseline (data collection: September 2010 
to March 2012) and first follow-up assessments, the latter conducted roughly 15 months after the baseline 
assessment (data collection: January 2012 to April 2013). 
 
Participants 
Of 7,563 conscripts who provided written consent to participate, 5,990 (79.2%) completed the baseline 
questionnaire. Of these, 5,223 (87.2%) also filled out the follow-up questionnaire. This study used data collected 
from those participants who completed both assessments. Additionally, 248 (4.7%) conscripts were excluded due 
to missing data on predictor variables. Thus, the final sample consisted of 4,975 subjects (95.3% of the follow-up 
sample). To avoid losing further data, subjects with missing values on certain outcomes were not excluded from 
analyses involving other outcomes. For the exact number of participants used for each outcome variable, see Table 
1. An analysis of possible non-response biases among the cohort of interest has been published previously [23]. 
Results from this prior investigation suggest that our participants and non-participants differed with respect to 
certain substance use outcomes. However, the differences identified were small, statistically significant mainly 
due to the large sample. Thus, we believe that non-response biases might only slightly affect the findings reported 
here. 
 
Independent Variables 
Adult ADHD 
ADHD over the past 12 months was assessed at the baseline assessment using the 6-item Adult ADHD Self-Report 
Scale Screener (ASRS-v1.1) [24, 25]. Summation scores were dichotomized into “no ADHD” (scores 0-13) and 
“ADHD” (scores 14-24). The cut-off score of 14 has been previously shown to be optimal for the classification of 
clinician-defined ADHD cases versus clinician-defined non-ADHD cases [25]. Participants were excluded when 
more than two items were left unanswered. Missing responses for those who failed to answer only one or two 
items were replaced using nearest-neighbour hot-deck imputations, applying a random recursive partitioning 
dissimilarity matrix, implemented within the RRP package [26] running in version 2.15 of the R software (R Team 
Core Development, 17). It should be noted that, although the ASRS can be used to screen for potential ADHD 
cases, it does not provide sufficient information to establish a formal clinical diagnosis, as per the DSM-IV. Thus, 
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in the context of our study, the term ADHD refers to people who reported ADHD symptoms and probably suffer 
from this disorder. 
 
Adjustment variables  
Subjects were screened for anti-social personality disorder (ASPD) at baseline using the Mini International 
Neuropsychiatric Interview (MINI plus, [27]). Answers were dichotomized to indicate the absence or presence of 
each symptom and coded as “no ASPD” or “ASPD”. ASPD was defined as at least two symptoms reported before 
and three symptoms after the age of 15. For participants who answered all but two or fewer items, the same 
imputation procedure was applied as for ADHD. Subjects who failed to answer three or more questions were 
excluded. 
Major Depression (MD) was assessed at follow-up using the Major Depressive Inventory (ICD-10) – WHO-MDI 
[28, 29]. Answers were dichotomized to indicate the absence or presence of each symptom, and coded as “no MD” 
or “MD”. MD was defined as at least five MDI items reported, with either item 1 or item 2 required to be among 
those five items [28]. Scores were computed when at least eight questions were answered.  
Socio-demographic variables included in the analyses were subject age, linguistic region, highest achieved 
education, and degree of financial autonomy, which were assessed at follow-up; and information about maternal 
education and family affluence, collected at baseline. Categories for these variables are indicated in Table 1. 
 
Outcome variables 
Risky substance use 
Risky alcohol use was assessed based on questions about the usual quantity and frequency of alcohol consumption 
and the frequency of risky single-occasion drinking (RSOD; consuming at least six standard drinks on a single 
occasion, over the last 12 months). This variable was dichotomized into “no risky use” (never or only occasionally 
drinking alcohol) versus “risky use” (either RSOD at least monthly, or risky-volume drinking). Risky-volume 
drinking was defined as drinking at least 21 standard drinks per week. For detailed information about the 
assessment and coding of these variables, see Gmel et al. [30]. 
Risky nicotine use was dichotomized into “no risky use” (never or only occasionally smoking cigarettes) versus 
“risky use” (smoking at least one cigarette daily).  
Risky cannabis use was dichotomized into “no risky use” (using cannabis at most once per week or not at all) 
versus “risky use” (using cannabis more than once weekly). The aforementioned variables were created for both 
the baseline and follow-up assessments.  
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To examine the course of risky alcohol, nicotine and cannabis use, a variable with four categories was created for 
each substance separately: 1) “absence of risky use” (no risky use reported at either data collection point); 2) 
“maturing out of risky use” (risky use at baseline, but not at follow-up); 3) “initiation of risky use” (no risky use 
reported at baseline, but reported at follow-up); and 4) “persistence of risky use” (risky use reported at both data 
collection points). 
SUD 
Alcohol use disorder (AUD) over the past 12 months was assessed via questionnaires, as in Knight et al. [31], 
including the additional criterion of “craving”. The questions were adapted from the Semi-Structured Assessment 
for the Genetics of Alcoholism (SSAGA) [32, 33]. In accordance with the DSM-5, AUD was defined as reporting 
at least two criteria [34]. From the responses, a binary variable was created (“no AUD” vs. “AUD”).  
Nicotine use disorder (NUD) was assessed using the Fagerström Test for Nicotine Dependence (FTND) revised 
version; [35, 36]. Summation scores were dichotomized into “no NUD” (scores 0-3) and “NUD” (scores 4-10) 
[37].  
Cannabis use disorder (CUD) was measured with the Cannabis Use Disorder Identification Test (CUDIT) revised 
version [38], modified according to Annaheim et al. [39]. Summation scores were dichotomized into “no CUD” 
(scores 0-7) and “CUD” (scores 8-40). All the above-mentioned dichotomized variables were generated at both 
data collection points.  
To investigate the course of AUD, NUD and CUD, a variable with four categories was created for each substance 
separately: 1) “absence of SUD” (no SUD of interest reported at either data collection point); 2) “maturing out of 
SUD” (the SUD of interest reported at baseline, but not at follow-up); 3) “initiation of SUD” (the SUD of interest 
not reported at baseline, but reported at follow-up); and 4) “persistence of SUD” (the SUD of interest reported at 
both assessments). 
 
Statistical analyses 
Data analysis was performed in SPSS 21.0. Socio-demographic, co-morbidity, and substance use characteristics 
were compared between participants with and without ADHD using Pearson chi-square analysis. To examine 
whether ADHD at baseline contributes to risky substance use (for alcohol, nicotine and cannabis) and related 
SUDs (AUD, NUD, CUD) at follow-up, binomial logistic regression analyses were performed for each of the six 
outcomes of interest. Odd ratios (ORs) were calculated between ADHD at baseline and each substance use 
outcome at follow-up, adjusting for 1) the corresponding risky use variable (i.e., risky use of alcohol, nicotine or 
cannabis) or SUD variable (i.e., AUD, NUD or CUD) at baseline alone; and 2) the corresponding risky use variable 
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(i.e., risky use of alcohol, nicotine or cannabis) or SUD variable (i.e., AUD, NUD or CUD) at baseline, socio-
demographic characteristics and co-morbid disorders (i.e., ASPD and MD). The presence of associations between 
ADHD and the course of risky substance use and SUDs were identified by means of multinomial logistic 
regression, again using ADHD as a predictor. These analyses were performed: 1) unadjusted, and 2) adjusted for 
socio-demographic characteristics and co-morbid disorders (i.e., ASPD and MD). 
To identify differences between men with ADHD who matured out and those who reported a persistent pattern 
over the investigation period, post hoc analyses were conducted for each of the three SUDs (i.e., AUD, NUD and 
CUD). Based on previous research, which indicated that the characteristics of ADHD, severity of SUD at baseline, 
and age of substance use initiation can influence the course of SUDs [21, 40–44], we tested whether the persisting 
and maturing-out groups differed with respect to 1) age at first use (< 16 vs. ≥ 16 years); 2) characteristics of 
ADHD (severity: size of score; type of symptoms: scores for 1. inattention and 2. hyperactivity-impulsivity); and 
3) severity of the SUD of interest (number of symptoms at baseline).  
 
Results 
Characteristics of participants with and without ADHD are compared in Tables 1 and 2.  
A total of 201 men screened positive and 4774 negative for ADHD. Compared to men without ADHD, those who 
endorsed ADHD symptoms tended to be older and from the French-speaking regions. They also were more likely 
to have completed primary school or have a high school/university-level education. Furthermore, relative to 
conscripts without ADHD, men reporting ADHD symptoms were more likely to report partial or complete 
financial dependency and had mothers who had completed high school/university or primary school only. 
Compared to men without ADHD, those with the disorder were also more likely to report ASPD and MD. Men 
with and without ADHD did not differ with respect to family affluence (for details, see Table 1). 
Relative to conscripts without ADHD, those with ADHD symptoms tended to report persistent risky use of alcohol, 
nicotine and cannabis. Men with ADHD also more often matured out of risky cannabis use than those without the 
disorder. Compared to men without ADHD, those reporting symptoms were also more likely to report persistent 
AUD, NUD and CUD and to have matured out of these SUDs (for details, see Table 2). 
 
Risky substance use 
Binomial logistic regression analyses revealed no significant associations between the presence of ADHD at 
baseline and risky substance use at follow-up for alcohol, nicotine or cannabis. This was true both after adjusting 
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only for the corresponding risky substance use variable at baseline, and after adjusting for the corresponding 
variable at baseline, as well as for socio-demographic characteristics and co-morbid disorders (Table 3). 
Multinomial logistic regression analyses, both unadjusted and adjusted for socio-demographics and co-morbidity, 
also identified no significant link between ADHD and maturing out of or initiating the use of licit substances in a 
risky manner at follow-up. However, relative to participants who did not report risky use at either time point 
(reference category), conscripts with ADHD were more likely to report persistent risky use of alcohol, nicotine, 
and cannabis than those without ADHD. Furthermore, more men with ADHD ceased risky cannabis consumption 
at follow-up (matured out) than those without the disorder. After adjusting for socio-demographics and co-
morbidity, ORs were reduced, but remained significantly elevated for persistent risky alcohol and nicotine use, 
and for discontinuing cannabis use, but not for persistent risky cannabis consumption (Table 4).  
SUD 
Binomial logistic regression analyses revealed a positive association between ADHD at baseline and AUD at 
follow-up, both after adjusting only for AUD at baseline, and after adjusting for AUD at baseline, as well as for 
socio-demographic characteristics and co-morbidity. Furthermore, an inverse relationship was detected between 
ADHD and CUD at follow-up after adjusting for CUD at baseline, socio-demographics and co-morbidity (Table 
3).  
Multinomial logistic regression analyses, unadjusted and adjusted for socio-demographics and co-morbidity, 
revealed a significant link between the presence of ADHD and reporting a persistent pattern of AUD, NUD and 
CUD, as well as between ADHD and maturing out at follow-up. Compared with conscripts who did not report 
SUDs (i.e., AUD, NUD or CUD) at baseline or follow-up (reference category), men with ADHD were more likely 
to report persistent AUD, NUD and CUD than those without. Also, more participants with ADHD had matured 
out of AUD, NUD and CUD at follow-up than men without this disorder (Table 4). 
Post hoc analysis of the men with ADHD revealed that those who matured out and those who had persistent AUD 
did not differ, with respect to characteristics of ADHD or AUD at baseline. However, participants with ADHD 
who continued to suffer from AUD at follow-up more commonly reported an earlier age at first alcohol use (i.e., 
before 16 years) (x2 (1) = 7.11, p = .008). Individuals with ADHD who matured out of NUD and those who reported 
a persistent pattern did not differ in age at nicotine use initiation, but the latter had significantly higher scores for 
ADHD (t(35.8) = -3.47, p = .001) (i.e., higher scores for inattention (t(34.7) = -3.50, p = .001)) and also for NUD 
at baseline (t(36) = -2.83, p = .008) than those who matured out. Relative to men who matured out of CUD, those 
who had persistent CUD reported higher scores for CUD at baseline (t(38) = -2.27, p = .029). Additionally, a trend 
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was found for hyperactivity symptoms, with men who matured out reporting higher scores for hyperactivity than 
those with persistent CUD (t(38) = 1.81, p = .078). No significant differences were found for age at first cannabis 
use. 
 
Discussion 
The two main purposes of the present study were: 1) to investigate whether ADHD predicts the risky use of 
particular substances (i.e., alcohol, nicotine, and cannabis) and related SUDs in young men followed for a period 
of 15 months; and 2) to examine for possible links between ADHD and the course (i.e., absence, initiation, 
maturing out, persistence) of problematic use patterns (i.e., risky use and SUD related to alcohol, nicotine and 
cannabis) over time. 
Contrary to our expectations, ADHD did not predict the risky use of alcohol or nicotine at follow-up, once we 
adjusted for the corresponding risky substance use variable at baseline. However, it is important to note that men 
with ADHD were more likely to already report risky consumption of these licit substances at baseline, and 
continued to exhibit these risky use patterns more often at follow-up than those without ADHD. Thus, by the time 
of the investigation (i.e., when they are in their early 20s), the men we studied with ADHD had already developed 
risky use patterns for licit substances that appeared to persist over time. Such a persistent pattern is problematic, 
because regular excessive use of such substances could potentially increase one’s risk of developing SUDs [6]. 
Additionally, alcohol and nicotine use at young ages are associated with other health-risk behaviours, their 
negative consequences, and various other adverse physical and mental health outcomes [6, 45–50]. Thus, 
continuing to use these substances in a risky manner over longer periods of time could, in the long-term, 
considerably compromise a person’s functioning and mental health. In particular, the impairments that adults with 
ADHD experience secondary to their symptoms could be exacerbated, causing further disadvantages in life 
domains that are already affected by this disorder (e.g., at work) [46]. Therefore, to prevent additional illness 
burden in subjects suffering from ADHD during later phases of life, further efforts should be undertaken to reduce 
regular risky use of both alcohol and nicotine in young adults. 
Our finding that ADHD at baseline predicted alcohol use disorder (AUD) at follow-up is consistent with those of 
two previously reported meta-analyses [10, 11]. Both included several prospective longitudinal studies and 
investigated subjects over a longer period of time than the present study, starting in childhood and following 
subjects into adolescence or even adulthood. During the short investigation period of our study, participants with 
ADHD did not develop an AUD more often than those without, but those who met the study criteria for an AUD 
at baseline continued to suffer from this disorder at follow-up (only 27.8% (30/108) matured out), while men 
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without ADHD were more likely to recover from AUD (42.5% (616/1451) matured out). Indeed, the results of 
multinomial regression analysis suggest that men with ADHD are more likely to continue to meet criteria for AUD 
over time than those without. Consistent with previously-published findings, this observation suggests that ADHD 
can have an adverse effect on the course of AUD, resulting in the condition being more likely to persist [13, 51, 
52]. Young men suffering from ADHD may experience more difficulties controlling their substance use [6, 12, 
53], and may need more support to overcome their alcohol-related problems than peers without ADHD.  
We also noted that ADHD was positively associated with maturing out, suggesting that at least some men with 
ADHD recover from AUD. To our knowledge, no previous studies have generated a similar observation. 
Therefore, we tried (post hoc) to identify characteristics that might help to explain the occurrence of the two 
different trajectories (i.e., maturing out and persistence of AUD) among participants with ADHD. Our analyses 
revealed that men with ADHD and a persistent AUD more often reported an earlier age at first alcohol use (i.e., 
before 16 years). This result is consistent with a recent longitudinal population-based study, in which individuals 
with childhood ADHD who had an AUD already in their teens also were more likely to satisfy criteria for AUD 
as adults, while those who did not were less likely to drink heavily or have an increased risk of AUD in adulthood 
[51]. Our results further suggest that men with ADHD who start alcohol use later may be more likely to recover 
from AUD. Age of initiation seems to be a target for prevention. Therefore, to avoid the development and 
persistence of AUD in young adults, preventive strategies and counselling aimed at preventing the initiation of 
alcohol use need to be implemented early in life (i.e., during childhood and adolescence). Furthermore, in young 
adults suffering from both ADHD and an AUD, efforts should be intensified to help them recover from this use 
disorder to avoid its long-term persistence. 
ADHD assessed at baseline did not predict nicotine use disorder (NUD) at follow-up. This result stands in contrast 
to a large body of literature addressing the relationship between ADHD and NUD (e.g., [7, 11, 43, 54]). However, 
this discrepancy might be caused by adjusting for NUD assessed at baseline, a procedure that was not applied in 
previous studies. Additionally, compared to the present study, these investigations started assessments during 
childhood or adolescence and followed subjects over a much longer period of time (i.e., 15-33 years). It is, 
therefore, also possible that our sample might be too old and/or the investigation period too short to identify a 
significant effect of ADHD on NUD. Indeed, our participants with ADHD were more likely to already have a 
NUD than those without ADHD at baseline (“ADHD”: 19.6%; “no ADHD”: 9.5%). Furthermore, a significant 
association between the presence of ADHD and persistence of NUD was evident. These results suggest that ADHD 
is, in fact, associated with an increased risk of NUD that most probably, typically develops before someone reaches 
20 years of age, and persists over time. The results are also consistent with those of previous studies, in which 
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individuals with ADHD experienced greater difficulty quitting smoking [14]. Furthermore, nicotine consumption 
has been frequently linked to self-medication for ADHD symptoms, particularly for those related to inattention 
[55, 56], which may further promote its regular use and, thereby, the persistence of NUD.  
We also uncovered a positive association between ADHD and maturing out of NUD. A post hoc comparison 
between men with ADHD who had a persistent NUD and those who matured out revealed a different pattern, as 
for AUD. Indeed, they did not differ with respect to age at initiation, but the former group reported significantly 
more ADHD symptoms, particularly inattention symptoms, and had higher scores for NUD at baseline than those 
who matured out. These findings confirm previous evidence that inattention symptoms are an important predictor 
of both the presence and severity of NUD [43, 54]. Treatments and prevention strategies designed to reduce 
inattention symptoms may thus help to prevent the development and persistence of NUD in young adults. 
ADHD at baseline did not predict risky cannabis use at follow-up. However, we found a positive link between 
ADHD and maturing out of both risky cannabis use, and cannabis use disorder (CUD). Furthermore, logistic 
regression analysis revealed a negative relationship between ADHD and CUD. This result can be explained by the 
higher number of men with ADHD who met criteria for CUD at baseline and matured out at follow-up (45%; 
106/332), while more men without ADHD continued to suffer from CUD (only 31.9% (18/40) matured out). 
Although men with ADHD ceased problematic cannabis consumption more often, a considerable proportion of 
these subjects still exhibited a persistent CUD at follow-up. Furthermore, in the study by Vogel et al. [22] over an 
interval of 15 months, more men with ADHD initiated cannabis use than those without; and even though at the 
follow-up assessment they did not meet criteria for risky consumption or SUDs, they could develop such 
problematic patterns later in life.  
Post hoc analysis revealed that men with ADHD who already had more severe CUD at baseline were more likely 
to show a persistent pattern. Thus, preventive strategies aiming to diminish symptoms of CUD in young adults 
may be crucial to preventing the persistence of this use disorder. Furthermore, a trend (p<.10) was found for 
hyperactivity-impulsivity symptoms, in that men who matured out had higher scores for hyperactivity-impulsivity 
than those who had CUD at both assessments. Several studies have identified an association between greater 
hyperactivity symptoms and the development or presence of CUD [21, 57–60], which may also reflect either the 
difficulty these individuals have regulating their behaviour, or attempts to self-medicate hyperactivity-impulsivity 
symptoms. From our data, we can only speculate as to why individuals with higher scores were more likely to 
recover from CUD, though it is possible that, after ceasing their cannabis consumption, they turned towards using 
other substances to alleviate their symptoms. In fact, Vogel and colleagues [22] found that men with ADHD at 
baseline were at risk of initiating the consumption of other illicit drugs and non-medical prescription drugs at 15-
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month follow-up. Whether there is a reduction in both cannabis use and related disorders, or a substitution with 
other drugs, needs to be clarified in future investigations. This is pivotal, if we are to take appropriate measures to 
design interventions that can truly help adults suffering from ADHD and avoid further burdens during later stages 
of life.  
This study has several limitations. First, women were excluded from our study, even though the associations we 
investigated may differ between men and women [40]. Second, ADHD, co-morbid disorders and SUDs were 
assessed by self-report and without including further confirmatory diagnostic assessments. However, all the 
instruments we used are well-validated scales, frequently utilized in previous research [25, 27–29, 32, 33, 35, 39]. 
Nevertheless, it is important to note that, with a cut-off of 14 points, the sensitivity of the ASRS Screener has been 
reported as only 64.9 % [25]. This means that a considerable number of ADHD cases might have screened 
negative. We expect that these individuals had less severe symptoms, on average, than those who screened positive 
[24]. This is mainly because the ASRS version we used (version 1.1) and the clinical interviews applied for its 
validation were based upon DSM-IV criteria that were originally developed for children and are too conservative 
for adults [61, 62]. For example, adults often exhibit fewer ADHD symptoms than children, but still experience 
significant functional impairment and mental health problems (e.g., SUDs). According to the DSM-IV definition, 
these individuals would fail to meet enough criteria for a clinical diagnosis of ADHD and would, therefore, be 
classified as non-cases. Because misclassified individuals with ADHD may also show risky substance use patterns 
or even suffer from SUDs, this misclassification may have biased our findings. Third, we did not assess subjects’ 
medical history for any of the disorders of interest; thus, their true clinical status was unknown. Additionally, no 
information was collected about received or current treatments, which may have influenced whether men with 
ADHD matured out or continued to suffer from SUDs. Fourth, we used the ASRS Screener, which was designed 
to assess ADHD as a total score and not to differentiate between inattention and hyperactivity-impulsivity 
symptoms. Therefore, even though our post hoc evaluations were consistent with previous studies [21, 63], future 
studies need to address the influence of each symptom type on the course of SUDs more thoroughly, using 
instruments that are suitable for assessing inattention and hyperactivity-impulsivity symptoms separately. Fifth, 
the investigation interval of 15 months was relatively short, and the number of subjects whose substance use 
changed over this period (i.e., those who matured out of or developed an SUD at follow-up) was small for some 
substances, like nicotine. Therefore, whether these trajectories reflect a constant phenomenon and not just 
temporary changes, or are the result of bias, must be addressed in future studies using longer intervals between 
assessments. Indeed, our findings may have been biased by drop-outs or the exclusion of participants with missing 
values for predictor variables. Those who fulfilled criteria for NUD or CUD at baseline were more likely to drop-
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up at follow-up or be excluded (data not shown) and, thereby, not be included in our final analysis. Furthermore, 
this difference was more prominent among those without ADHD (NUD: men with ADHD, x2 = 0.72, p = .39; men 
without ADHD, x2 = 68.58, p < .001; CUD: men with ADHD, x2 = 3.04, p = .08; men without ADHD, x2 = 45.73, 
p < .001), and this imbalance between the two groups may have biased the results. Finally, it must be noted that 
the observation that men with ADHD do mature out of AUD, NUD and CUD more often than those without 
ADHD is unexpected and cannot be explained on the basis of previous findings. One possible explanation is that 
people with ADHD may have been more likely to attend regular therapy sessions with a psychiatrist than those 
without ADHD, where mention of their substance problems could have led either to appropriate therapy or to self-
discovery of strategies that they could then use to control their behaviours. However, it is also possible that the 
maturing out we observed might only reflect a change in their primary substance of use [22]. To shed light on this 
particular trajectory, further investigations that incorporate detailed medical and treatment histories are required.  
Conclusions 
In conclusion, over a relatively brief time window of 15 months, we found that ADHD was linked to the persistence 
of risky alcohol and nicotine consumption, but also to the maturing out of risky cannabis use. These findings are 
somewhat consistent with those observed for more severe consumption patterns (i.e., related SUDs). In fact, 
ADHD was identified as a risk factor for AUD and was negatively associated with CUD. Examination of the 
courses of AUD, NUD and CUD revealed that, for these disorders, ADHD is essentially associated with two 
trajectories: 1) persistence, and 2) maturing out of problematic use. Identifying characteristics that distinguish 
between adults exhibiting persistence versus maturing out could help to detect subjects who are at risk of ultimately 
developing addictions, and might aid in designing appropriate prevention strategies that better fit the needs of 
young men with ADHD. Our evaluation also suggests that the relevance of certain characteristics may differ, 
depending on the substance. Thus, substance-specific preventive interventions may be central to reducing the risk 
and persistence of SUDs. Finally, our findings indicate that, as early as their early 20s, men with ADHD are more 
likely to have problematic substance use. Moreover, though some mature out of this use over time, for most these 
patterns appear to persist over time, suggesting that, by this age, the damage may be already done. Preventive 
strategies may, therefore, be more successful when administered before early adulthood. Given the short 
observation period in the present study, our results, particularly those related to maturing out, need to be 
corroborated in future follow-up studies with a longer interval between assessments. 
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Table 1 Socio-demographic characteristics and co-morbid variables according to adult ADHD.  
  
  
Participants  
without ADHD 
Participants  
with ADHD 
  
 
 
 
Totala n % n % X2 p  
Socio-demographics 
       
 
Ageb 4975              
<21   2321 48.6 80 39.8 6.00 0.014  
>=21   2453 51.4 121 60.2      
Linguistic regionb 4975              
German   2246 47.0 62 30.8 20.36 0.000  
French   2528 53.0 139 69.2      
Educationb 4975              
primary school   387 8.1 30 14.9 18.65 0.000  
secondary vocational school   2161 45.3 66 32.8      
high school/university   2226 46.6 105 52.2      
Financial autonomyb 4975              
financial autonomy   1802 37.7 45 22.4 21.51 0.000  
partial financial dependency   1885 39.5 91 45.3      
financial dependency   1087 22.8 65 32.3      
Mother's educationc 4975              
primary school   594 12.4 32 15.9 14.85 0.001  
secondary vocational school   3033 63.5 101 50.2      
high school/university   1147 24.0 68 33.8      
Family affluencec 4975              
above average   2169 45.4 81 40.3 3.40 0.182  
average   1942 40.7 84 41.8      
below average   663 13.9 36 17.9      
                 
Co-morbid disorders                
ASPDc 4975              
no   4049 84.8 131 65.2 55.41 0.000  
yes   725 15.2 70 34.8      
MDb 4975              
no   4651 97.4 178 88.6 53.23 0.000  
yes   123 2.6 23 11.4      
ADHD: Attention-deficit/hyperactivity disorder; ASPD: Anti-social personality disorder; MD: Major depression; 
a
 Total number of participants (n) recorded for this variable; b Variable was assessed at follow-up; c Variable was assessed at 
baseline. 
Table 2 Substance use outcomes according to adult ADHD.  
    
Participants  
without ADHD 
Participants  
with ADHD 
  
  Totala n % n % X2 p 
Alcohol 
              
Risky alcohol use 4907             
absence of risky use   2051 43.5 74 37.8 9.98 0.019 
maturing out of risky use   577 12.2 19 9.7     
initiation of risky use   477 10.1 15 7.7     
persistence of risky use   1606 34.1 88 44.9     
                
AUD 4942             
absence of AUD   2671 56.3 67 33.8 67.18 0.000 
maturing out of AUD   616 13.0 30 15.2     
initiation of AUD   622 13.1 23 11.6     
persistence of AUD   835 17.6 78 39.4     
                
Nicotine               
Risky nicotine use 4968             
absence of risky use   3672 77.0 131 65.2 20.07 0.000 
maturing out of risky use   138 2.9 7 3.5     
initiation of risky use   244 5.1 10 5.0     
persistence of risky use   713 15.0 53 26.4     
                
NUD 4531             
absence of NUD   3759 86.7 148 76.3 21.66 0.000 
maturing out of NUD   137 3.2 13 6.7     
initiation of NUD   168 3.9 8 4.1     
persistence of NUD   273 6.3 25 12.9     
                
Cannabis               
Risky cannabis use 4975             
absence of risky use   4301 90.1 158 78.6 31.19 0.000 
maturing out of risky use   119 2.5 15 7.5     
initiation of risky use   90 1.9 7 3.5     
persistence of risky use   264 5.5 21 10.4     
                
CUD 4942             
absence of CUD   4304 90.6 149 76.8 56.96 0.000 
maturing out CUD   106 2.2 18 9.3     
initiation of CUD   112 2.4 5 2.6     
persistence of CUD   226 4.8 22 11.3     
ADHD: Attention-deficit/hyperactivity disorder; AUD: Alcohol use disorder; NUD: Nicotine use disorder;  
CUD: Cannabis use disorder; 
a
 Total number of participants (n) recorded for this variable, n varies slightly between variables due to missing data. 
 
Table 3 Logistic regression analyses with risky use of alcohol, nicotine and cannabis and related SUDs as outcome. 
  Risky alcohol useb   Risky nicotine useb   Risky cannabis useb 
  AORc [CI] AORd [CI]   AORc [CI] AORd [CI]   AORc [CI] AORd [CI] 
ADHDa                 
no 1.00 1.00   1.00 1.00   1.00 1.00 
yes 1.24 [0.88, 1.75] 1.22 [0.86, 1.74]   1.27 [0.78, 2.06] 1.16 [0.69, 1.94]   1.00 [0.55, 1.83] 0.75 [0.39, 1.42] 
                  
  AUDb  NUDb  CUDb 
  AORc [CI] AORd [CI]   AORc [CI] AORd [CI]   AORc [CI] AORd [CI] 
ADHDa                 
no 1.00 1.00   1.00 1.00   1.00 1.00 
yes 1.70 [1.25, 2.33]*** 1.53 [1.11, 2.12]**   1.07 [0.64, 1.81] 0.90 [0.51, 1.57]   0.73 [0.41, 1.31] 0.52 [0.28, 0.98]* 
ADHD: Attention-deficit/hyperactivity disorder; AUD: Alcohol use disorder; NUD: Nicotine use disorder; CUD: Cannabis use disorder; 
*p < .05, **p < .01, ***p < .001;  
OR: Odds ratio; CI: 95% confidence interval;  
a Variable was assessed at baseline; b Variable was assessed at follow-up; c Adjusted for outcome of interest at baseline; d Adjusted for outcome of interest at baseline, socio-demographic variables 
and co-morbid disorders. 
Table 4 Multinomial regression analyses with risky use of alcohol, nicotine and cannabis and related SUDs as outcome. 
Risky alcohol use               
  maturing outa   initiationa   persistencea 
  Crude OR [CI] AORb [CI]   Crude OR [CI] AORb [CI]   Crude OR [CI] AORb [CI] 
ADHD                 
no 1.00 1.00   1.00 1.00   1.00 1.00 
yes 0.91 [0.55, 1.52] 0.96 [0.57, 1.62]   0.87 [0.50, 1.53] 0.93 [0.52, 1.64]   1.52 [1.11, 2.08]** 1.45 [1.04, 2.02]* 
                  
Risky nicotine use               
  maturing outa   initiationa   persistencea 
  Crude OR [CI] AORb [CI]   Crude OR [CI] AORb [CI]   Crude OR [CI] AORb [CI] 
ADHD                 
no 1.00 1.00   1.00 1.00   1.00 1.00 
yes 1.42 [0.65, 3.10] 1.14 [0.51, 2.55]   1.15 [0.60, 2.21] 1.00 [0.51, 1.97]   2.08 [1.50, 2.90]*** 1.75 [1.22, 2.51]** 
                  
Risky cannabis use               
  maturing outa   initiationa   persistencea 
  Crude OR [CI] AORb [CI]   Crude OR [CI] AORb [CI]   Crude OR [CI] AORb [CI] 
ADHD                 
no 1.00 1.00   1.00 1.00   1.00 1.00 
yes 3.43 [1.96, 6.01]*** 2.71 [1.50, 4.92]***   2.12 [0.97, 4.64]† 1.62 [0.72, 3.65]   2.17 [1.35, 3.47]*** 1.33 [0.80, 2.21] 
  
                  
AUD               
  maturing outa   initiationa   persistencea 
  Crude OR [CI] AORb [CI]   Crude OR [CI] AORb [CI]   Crude OR [CI] AORb [CI] 
ADHD                 
no 1.00 1.00   1.00 1.00   1.00 1.00 
yes 1.94 [1.25, 3.01]** 1.76 [1.12, 2.77]*   1.47 [0.91, 2.39] 1.32 [0.81, 2.16]   3.72 [2.66, 5.21]*** 3.10 [2.16, 4.45]*** 
         
NUD               
  maturing outa   initiationa   persistencea 
  Crude OR [CI] AORb [CI]   Crude OR [CI] AORb [CI]   Crude OR [CI] AORb [CI] 
ADHD                 
no 1.00 1.00   1.00 1.00   1.00 1.00 
yes 2.41 [1.33, 4.36]** 2.27 [1.21, 4.24]*   1.21 [0.58, 2.50] 1.08 [0.51, 2.29]   2.33 [1.50, 3.62]*** 1.97 [1.21, 3.20]** 
         
CUD               
  maturing outa   initiationa   persistencea 
  Crude OR [CI] AORb [CI]   Crude OR [CI] AORb [CI]   Crude OR [CI] AORb [CI] 
ADHD                 
no 1.00 1.00   1.00 1.00   1.00 1.00 
yes 4.91 [2.90, 8.30]*** 3.65 [2.08, 6.42]***   1.29 [0.52, 3.21] 1.00 [0.39, 2.55]   2.81 [1.76, 4.49]*** 1.69 [1.02, 2.82]* 
ADHD: Attention-deficit/hyperactivity disorder; AUD: Alcohol use disorder; NUD: Nicotine use disorder; CUD: Cannabis use disorder; 
†p < .10, *p < .05, **p < .01, ***p < .001;  
OR: Odds ratio; CI: 95% confidence interval;  
a
 Reference category: absence of the outcome of interest (e.g., absence of AUD); b Adjusted for socio-demographic variables and co-morbid disorders.  
